Watson Pharmaceuticals Inc. (WPI) has received a request for additional information from the Federal Trade Commission or "FTC" relating to Watson's pending acquisition of Actavis Group. The information request was issued under notification requirements of the Hart.Scott Rodino Antitrust Improvements Act of 1976, as amended or "HSR Act".
The effect of the second request is to extend the waiting period imposed by the HSR Act until 30 days after Watson and Actavis have complied with the request, unless that period is extended voluntarily by the parties or terminated sooner by the FTC.
Watson plans to cooperate with the FTC's review and expects the transaction to be complete in the fourth quarter of 2012.
Click here to receive FREE breaking news email alerts for Actavis Inc. and others in your portfolio
by RTT Staff Writer
For comments and feedback: firstname.lastname@example.org